Results 241 to 250 of about 11,948,174 (351)
Are New β-Lactam/β-Lactamase Inhibitor Combinations Promising Against Carbapenem-Resistant K. pneumoniae Isolates? [PDF]
Ceylan AN +5 more
europepmc +1 more source
Local application of gentamicin for wound closure after full‐support microaxial flow pump therapy. ABSTRACT Background Surgically implanted microaxial flow pumps (mAFP) are increasingly used for cardiogenic shock treatment. Standard mAFP explantation is performed bedside with a shortening of the vascular prosthesis, which may represent a potential ...
Gaik Nersesian +11 more
wiley +1 more source
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections- results from a retrospective multicentre study. [PDF]
Marino A +18 more
europepmc +1 more source
Infection control in the brain and the eye
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester +2 more
wiley +1 more source
Clinical and Microbiological characteristics of patients with ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains. [PDF]
Liu SY +7 more
europepmc +1 more source
Lateral flow immunoassay for simultaneous detection of C. difficile, MRSA, and K. pneumoniae. [PDF]
Rubio-Monterde A +4 more
europepmc +1 more source
Niosome-loaded Tet-Amp against S. aureus, K. pneumoniae, and P. aeruginosa. [PDF]
Bazargan E, Ashrafi F, Torbati ES.
europepmc +1 more source

